ConductScience.org, home

Paper30936623

Human-specific dual regulations of FXR-activation for reduction of fatty liver using in vitro cell culture model.

Miyazaki T and 4 others. J Clin Biochem Nutr, 2019. Cited by 8 papers, by iCite.

Cite this record

ConductScience Library. Human-specific dual regulations of FXR-activation for reduction of fatty liver using in vitro cell culture model. Papers, record 30936623. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/30936623

Download JSON
Sources
11 sources
Release
papers-2026-11-12-0.1.0

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
Human-specific dual regulations of FXR-activation for reduction of fatty liver using in vitro cell culture model.
PubMed
Journal
J Clin Biochem Nutr
PubMed
Year
2019
PubMed
Publication types
Journal Article
PubMed
Citations, by iCite
8
iCite
Relative citation ratio, by iCite
0.35
iCite
Revised in PubMed
2020-10-01
PubMed

Authors5

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Miyazaki TTeruo
2Honda AAkira
3Ikegami TTadashi
4Iida TTakashi
5Matsuzaki YYasushi

Source PubMed

Download CSV of authors

Topics0

NLM's MeSH indexing of the paper, its major topics first.

None in this release.

References56

The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.

OrderPMIDTitleJournalYearIn PapersSource
110334992Identification of a nuclear receptor for bile acids.Science1999https://conductscience.org/library/papers/10334992PubMed
210334993Bile acids: natural ligands for an orphan nuclear receptor.Science1999https://conductscience.org/library/papers/10334993PubMed
310360171Endogenous bile acids are ligands for the nuclear receptor FXR/BAR.Mol Cell1999https://conductscience.org/library/papers/10360171PubMed
410385632Long-term ursodeoxycholic acid therapy is associated with reduced risk of biliary pain and acute cholecystitis in patients with gallbladder stones: a cohort analysis.Hepatology1999https://conductscience.org/library/papers/10385632PubMed
510529898Peroxisome proliferator-activated receptors: nuclear control of metabolism.Endocr Rev1999https://conductscience.org/library/papers/10529898PubMed
610956205Identification of a chemical tool for the orphan nuclear receptor FXR.J Med Chem2000https://conductscience.org/library/papers/10956205PubMed
711090131Role of LXRs in control of lipogenesis.Genes Dev2000https://conductscience.org/library/papers/11090131PubMed
811171976Expression of sterol regulatory element-binding protein 1c (SREBP-1c) mRNA in rat hepatoma cells requires endogenous LXR ligands.Proc Natl Acad Sci U S A2001https://conductscience.org/library/papers/11171976PubMed
911266382Nonalcoholic steatohepatitis: association of insulin resistance and mitochondrial abnormalities.Gastroenterology2001https://conductscience.org/library/papers/11266382PubMed
10121669276alpha-ethyl-chenodeoxycholic acid (6-ECDCA), a potent and selective FXR agonist endowed with anticholestatic activity.J Med Chem2002https://conductscience.org/library/papers/12166927PubMed
1112381268Peroxisome proliferator-activated receptor alpha (PPARalpha)-mediated regulation of multidrug resistance 2 (Mdr2) expression and function in mice.Biochem J2003https://conductscience.org/library/papers/12381268PubMed
1212524534Reciprocal regulation of inflammation and lipid metabolism by liver X receptors.Nat Med2003https://conductscience.org/library/papers/12524534PubMed
1312554753Bile acids induce the expression of the human peroxisome proliferator-activated receptor alpha gene via activation of the farnesoid X receptor.Mol Endocrinol2003https://conductscience.org/library/papers/12554753PubMed
1412554795Differential regulation of rat and human CYP7A1 by the nuclear oxysterol receptor liver X receptor-alpha.Mol Endocrinol2003https://conductscience.org/library/papers/12554795PubMed
1512746275Minireview: lipid metabolism, metabolic diseases, and peroxisome proliferator-activated receptors.Endocrinology2003https://conductscience.org/library/papers/12746275PubMed
1614527955Farnesoid X receptor activates transcription of the phospholipid pump MDR3.J Biol Chem2003https://conductscience.org/library/papers/14527955PubMed
1714623915Hepatoprotection by the farnesoid X receptor agonist GW4064 in rat models of intra- and extrahepatic cholestasis.J Clin Invest2003https://conductscience.org/library/papers/14623915PubMed
1814722322Induction of drug metabolism enzymes and MDR1 using a novel human hepatocyte cell line.J Pharmacol Exp Ther2004https://conductscience.org/library/papers/14722322PubMed
1915146238Bile acids lower triglyceride levels via a pathway involving FXR, SHP, and SREBP-1c.J Clin Invest2004https://conductscience.org/library/papers/15146238PubMed
2015317466Bile acid derivatives as ligands of the farnesoid X receptor. Synthesis, evaluation, and structure-activity relationship of a series of body and side chain modified analogues of chenodeoxycholic acid.J Med Chem2004https://conductscience.org/library/papers/15317466PubMed

See all 56 referencesDownload CSV of references

Cited by3

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 8 citations.

PMIDTitleJournalYearIn PapersSource
37514148Pharmaceutical Strategies to Improve Druggability of Potential Drug Candidates in Nonalcoholic Fatty Liver Disease Therapy.Pharmaceutics2023https://conductscience.org/library/papers/37514148PubMed
32801472Prevention effect of quercetin and its glycosides on obesity and hyperglycemia through activating AMPKα in high-fat diet-fed ICR mice.J Clin Biochem Nutr2020https://conductscience.org/library/papers/32801472PubMed
32801462Epigallocatechin-3-gallate (EGCG) attenuates non-alcoholic fatty liver disease via modulating the interaction between gut microbiota and bile acids.J Clin Biochem Nutr2020https://conductscience.org/library/papers/32801462PubMed

Download CSV of cited by

Genes18

The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.

GeneNCBI Gene IDLinked byIn GenesSource
ABCB45244PubTator's text mininghttps://conductscience.org/library/genes/5244NCBI Gene
ACACA31PubTator's text mininghttps://conductscience.org/library/genes/31NCBI Gene
APOE348PubTator's text mininghttps://conductscience.org/library/genes/348NCBI Gene
CDH111009PubTator's text mininghttps://conductscience.org/library/genes/1009NCBI Gene
CPT1A1374PubTator's text mininghttps://conductscience.org/library/genes/1374NCBI Gene
FAS355PubTator's text mininghttps://conductscience.org/library/genes/355NCBI Gene
INS3630PubTator's text mininghttps://conductscience.org/library/genes/3630NCBI Gene
LDLR3949PubTator's text mininghttps://conductscience.org/library/genes/3949NCBI Gene
NR0B28431PubTator's text mininghttps://conductscience.org/library/genes/8431NCBI Gene
NR1H310062PubTator's text mininghttps://conductscience.org/library/genes/10062NCBI Gene
NR1H49971PubTator's text mininghttps://conductscience.org/library/genes/9971NCBI Gene
POTEF728378PubTator's text mininghttps://conductscience.org/library/genes/728378NCBI Gene
PPARA5465PubTator's text mininghttps://conductscience.org/library/genes/5465NCBI Gene
SCD6319PubTator's text mininghttps://conductscience.org/library/genes/6319NCBI Gene
SLC22A56584PubTator's text mininghttps://conductscience.org/library/genes/6584NCBI Gene
SREBF16720PubTator's text mininghttps://conductscience.org/library/genes/6720NCBI Gene
TF7018PubTator's text mininghttps://conductscience.org/library/genes/7018NCBI Gene
TNF7124PubTator's text mininghttps://conductscience.org/library/genes/7124NCBI Gene

Download CSV of genes

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Grants
  • Trials
  • Comments and corrections
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/30936623

GET https://conductscience.org/api/papers/v1/30936623/references?page=2